PSSA3:BMFBOVESPAPorto Seguro S.A. Analysis
Data as of 2026-03-17 - not real-time
R$47.34
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Porto Seguro is trading at R$47.34, comfortably below its 20‑day (R$50.77), 50‑day (R$49.85) and 200‑day (R$50.20) moving averages, indicating short‑term weakness. The RSI of 33 suggests the stock is approaching oversold territory, while a bearish MACD and stable volume reinforce a cautious near‑term outlook. Yet the market sentiment is extremely bullish, with the Fear & Greed Index at 79.45 (Extreme Greed) and volatility at a high 27.6% over the past month.
Fundamentally, the company posted R$43.3 bn in revenue growing 29% YoY, and trades at a PE of 9.1 versus an industry average of 16.5, highlighting a clear valuation discount. A dividend yield of 4.95% with a payout ratio just under 50% points to sustainable income, and the DCF model implies a fair value near R$74, offering roughly 15% upside to current levels. Analysts collectively rate the stock as a “buy” with median price targets around R$55.
Risk is moderated by a low beta of 0.29, solid operating cash flow, and decent liquidity (average 10‑day volume ~1.67 m shares). However, moderate leverage (debt‑to‑equity ~4.5) and Brazil‑specific regulatory and currency exposure temper the profile. Overall, the blend of attractive valuation, strong dividend, and growth prospects supports a buy stance for medium to long horizons, while short‑term positioning remains neutral pending a technical bounce.
Fundamentally, the company posted R$43.3 bn in revenue growing 29% YoY, and trades at a PE of 9.1 versus an industry average of 16.5, highlighting a clear valuation discount. A dividend yield of 4.95% with a payout ratio just under 50% points to sustainable income, and the DCF model implies a fair value near R$74, offering roughly 15% upside to current levels. Analysts collectively rate the stock as a “buy” with median price targets around R$55.
Risk is moderated by a low beta of 0.29, solid operating cash flow, and decent liquidity (average 10‑day volume ~1.67 m shares). However, moderate leverage (debt‑to‑equity ~4.5) and Brazil‑specific regulatory and currency exposure temper the profile. Overall, the blend of attractive valuation, strong dividend, and growth prospects supports a buy stance for medium to long horizons, while short‑term positioning remains neutral pending a technical bounce.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below key moving averages signals weakness
- RSI near oversold levels may trigger a bounce
- Bearish MACD and high short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount (PE 9.1 vs industry 16.5)
- Strong dividend yield of 4.95% with sustainable payout
- Robust revenue growth of 29% and analyst buy rating
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Diversified insurance and financial services platform
- Low beta indicating defensive characteristics
- DCF fair value suggests substantial upside and durable cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth29.10%
Profit Margin7.81%
P/E Ratio9.1
ROE22.82%
ROA6.11%
Debt/Equity4.54
P/B Ratio1.9
Op. Cash FlowR$1.4B
Free Cash FlowR$-219600256
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI33.0
SupportR$0.00
ResistanceR$53.10
MA 20R$50.77
MA 50R$49.85
MA 200R$50.20
MACDBearish
VolumeStable
Fear & Greed Index79.45
Valuation
Fair ValueR$74.00
Target PriceR$54.36
Upside/Downside14.84%
GradeUndervalued
TypeBlend
Dividend Yield4.95%
Risk Assessment
Beta0.29
Volatility27.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.